Tom Livne

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.

XTEND provides revolutionary human-guided autonomous machine systems that enable any operator to perform extremely accurate maneuvers and actions, in any environment with minimal training. The companys patented XOS operating system fuses the best of human intelligence and machine autonomy to enhance the operators abilities, and simultaneously reduce the need for physical confrontation, thereby minimizing casualties and injuries. Hundreds of XTENDs systems are already operationally deployed worldwide, and the company is continuously developing its XOS operating system and platforms to deliver the future of human-machine teaming to defense, public safety, and security professionals worldwide.

Receiving stock options can be a life-changing financial opportunity. But, startup employees often struggle to afford the exercise cost. With Equitybee, you can get funding to exercise your options, plus an upfront payment. You remain the owner of the shares so you can enjoy potential future profit as well.

Pagaya is a financial technology company that enables financial institutions to expand access to more customers through its artificial intelligence network

Sequent is a flexible online voting solution built to simplify your election processes while ensuring the highest level of confidence, security, transparency, and verifiability. Sequents proprietary technology utilizes proven cryptography to ensure elections are end-to-end verifiable. Voters can verify their vote was cast & counted accurately, and election auditors can verify the election results correctly. It is also capable of accommodating elections of any size and complexity.

Seemore Data is an end-to-end, data product optimization platform, built to attribute data spend and maximize data ROI, across all pipelines and stacks. With full lineage visibility and data cost root-cause analysis, we help data and business leaders understand the ‘why’ and ‘where’ behind spend and business impact, to drive real business growth.

Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patients neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.

Own Company is the leading data platform trusted by thousands of organizations to protect and activate SaaS data to transform their businesses. Own empowers customers to ensure the availability, security, and compliance of mission-critical data, while unlocking new ways to gain deeper insights faster. By partnering with some of the world’s largest SaaS ecosystems such as Salesforce, ServiceNow, and Microsoft Dynamics 365, Own enables customers around the world to truly own the data that powers their business. ‍ It’s their platform. It’s your data. Own it.

Session42 is at the forefront of a new era in the music industry, where technology and artistry intersect. Born as a music label, weve evolved into a pioneering tech company, yet our roots in empowering artists remain strong. Were on a mission to revolutionize the music creation, distribution, and monetization process, leveraging advanced AI and automation. Were currently developing a groundbreaking AI solution called HitCraft that promises to redefine the music production landscape. Our mission is to democratize access to high-quality music production, bridging the gap between technology and artistic expression. HitCraft, is the worlds first AI-powered virtual producer. It integrates with traditional workflows, using AI to help artists and producers craft high-quality tracks effortlessly. Continuously learning from a vast music library, HitCraft makes professional production accessible to everyone, fostering creativity and collaboration. Sign up now to HitCraft at www.hitcraft.ai

Redefining the future of the cybersecurity frontier by developing highly-skilled next-generation talents.

At Pery, we believe better care starts with better engagement - and better engagement starts with data. Pery is an AI-powered Patient Data Platform that helps behavioral health clinics and systems reduce no-shows, increase billable sessions, and support care teams without adding more admin work. We unify data from your existing systems and combine it with real-time patient input through a mobile app. Our AI turns it into risk alerts, care recommendations, and automated follow-ups - all within your current workflow. Built for behavioral health. Proven to drive results.

Online shopping can be overwhelming. Roundforest’s mission is to make the consumer shopping journey simpler - helping them make better & quicker shopping decisions and ultimately buy with certainty. Roundforest has created an end-to-end shopping ecosystem comprised of our proprietary websites, native publisher solution, social shopping community, and email newsletters. Our unique approach to leveraging advanced data-technology allows us to identify the best product for each customer and provide highly specific buying recommendations—taking the uncertainty out of online shopping. A few of our leading consumer brands are BestReviews.Guide, BestDeals.Today, AskAdam and Cherry which reach over 40M shoppers every month who make over $1B in purchases each year based on our personalized product recommendations.

As the usage of commercial drones continues to proliferate, security officers to sensitive sites are facing escalating threats. To safeguard their sky perimeters against unauthorized drones, they are seeking an effective response that is tailored to their specific needs without compromising any existing security frameworks. Ensuring the safety and protection of communities – including people, assets and critical infrastructures- necessitates a comprehensive approach that goes beyond simply implementing more technology. This multifaceted challenge can only be addressed through tight collaboration among the key stakeholders in the drone ecosystem, including regulatory bodies, unmanned traffic management players, technology vendors and drone users. Recognizing the critical nature and complexity of this challenge, the Sentrycs team of Communications and Radio Frequency experts embarked on a mission in 2017 to develop modular solutions that can be fully customized to precisely meet the unique security requirements and drone ecosystems of each customer and partner. By uniting its field-proven technology and expertise in global drone environments, Sentrycs is leading the way towards a safer and more secure drone-driven future.

We power businesses with the best digital data. Our mission is to create the most accurate, comprehensive, and actionable digital data, so every business can win their market. Digital is now the most important driver of growth and profitability for just about every business. Similarweb is a platform that gives our customers a true 360 degree view of all digital activity across customers, prospects, partners, and competition. The resulting insights give our customers — who are some of the world’s biggest brands — a digital edge that helps them beat their competition and win their markets. Listed on NYSE: #SMWB Trusted by Jimmy Kimmel: https://bit.ly/41DW62X In numbers: Founded in 2009 1,200 employees globally 10,000+ customers 14 global offices Services in 100+ countries

NewVest is an institutional platform of index funds designed to provide investors with diversified, passive exposure to private markets, similar to how ETFs and Index Funds provide passive exposure to public markets. Our no management fee funds seek to generate returns that closely emulate the historically attractive pooled returns of an asset or sub-asset class with significantly lower risk than investing in individual private funds.

Iron Dome Acquisition I Corp. is a technology-focused special purpose acquisition company targeting high-growth businesses across cybersecurity, artificial intelligence, defense technology, and data infrastructure. The company is led by an experienced team of operators, investors, and executives with deep expertise in capital markets, enterprise software, cybersecurity, M&A, and scaling global technology companies. Iron Dome’s mission is to partner with a category-defining Israeli technology company and support its evolution into a durable, world-class public company.

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.

XTEND provides revolutionary human-guided autonomous machine systems that enable any operator to perform extremely accurate maneuvers and actions, in any environment with minimal training. The companys patented XOS operating system fuses the best of human intelligence and machine autonomy to enhance the operators abilities, and simultaneously reduce the need for physical confrontation, thereby minimizing casualties and injuries. Hundreds of XTENDs systems are already operationally deployed worldwide, and the company is continuously developing its XOS operating system and platforms to deliver the future of human-machine teaming to defense, public safety, and security professionals worldwide.